Medical - Devices
Compare Stocks
2 / 10Stock Comparison
PHG vs SYK
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Devices
PHG vs SYK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Devices | Medical - Devices |
| Market Cap | $25.90B | $111.96B |
| Revenue (TTM) | $17.83B | $25.12B |
| Net Income (TTM) | $895M | $3.25B |
| Gross Margin | 45.2% | 63.5% |
| Operating Margin | 8.0% | 22.4% |
| Forward P/E | 17.6x | 19.5x |
| Total Debt | $8.09B | $14.86B |
| Cash & Equiv. | $2.79B | $4.01B |
PHG vs SYK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Koninklijke Philips… (PHG) | 100 | 66.0 | -34.0% |
| Stryker Corporation (SYK) | 100 | 149.4 | +49.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PHG vs SYK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PHG is the clearest fit if your priority is value and dividends.
- Lower P/E (17.6x vs 19.5x)
- 1.5% yield, 1-year raise streak, vs SYK's 1.1%
- +17.0% vs SYK's -21.7%
SYK carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 34 yrs, beta 0.55, yield 1.1%
- Rev growth 11.2%, EPS growth 8.2%, 3Y rev CAGR 10.8%
- 185.6% 10Y total return vs PHG's 47.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.2% revenue growth vs PHG's -1.0% | |
| Value | Lower P/E (17.6x vs 19.5x) | |
| Quality / Margins | 12.9% margin vs PHG's 5.0% | |
| Stability / Safety | Beta 0.55 vs PHG's 1.12, lower leverage | |
| Dividends | 1.5% yield, 1-year raise streak, vs SYK's 1.1% | |
| Momentum (1Y) | +17.0% vs SYK's -21.7% | |
| Efficiency (ROA) | 6.9% ROA vs PHG's 3.4%, ROIC 11.4% vs 6.4% |
PHG vs SYK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
PHG vs SYK — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
SYK leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SYK and PHG operate at a comparable scale, with $25.1B and $17.8B in trailing revenue. SYK is the more profitable business, keeping 12.9% of every revenue dollar as net income compared to PHG's 5.0%. On growth, SYK holds the edge at +11.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $17.8B | $25.1B |
| EBITDAEarnings before interest/tax | $2.5B | $6.3B |
| Net IncomeAfter-tax profit | $895M | $3.2B |
| Free Cash FlowCash after capex | $755M | $4.3B |
| Gross MarginGross profit ÷ Revenue | +45.2% | +63.5% |
| Operating MarginEBIT ÷ Revenue | +8.0% | +22.4% |
| Net MarginNet income ÷ Revenue | +5.0% | +12.9% |
| FCF MarginFCF ÷ Revenue | +4.2% | +17.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.1% | +11.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.1% | +56.0% |
Valuation Metrics
PHG leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 24.9x trailing earnings, PHG trades at a 28% valuation discount to SYK's 34.8x P/E. On an enterprise value basis, PHG's 10.7x EV/EBITDA is more attractive than SYK's 20.2x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $25.9B | $112.0B |
| Enterprise ValueMkt cap + debt − cash | $32.1B | $122.8B |
| Trailing P/EPrice ÷ TTM EPS | 24.95x | 34.80x |
| Forward P/EPrice ÷ next-FY EPS est. | 17.59x | 19.49x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.34x |
| EV / EBITDAEnterprise value multiple | 10.73x | 20.19x |
| Price / SalesMarket cap ÷ Revenue | 1.24x | 4.46x |
| Price / BookPrice ÷ Book value/share | 2.03x | 4.98x |
| Price / FCFMarket cap ÷ FCF | 24.72x | 26.14x |
Profitability & Efficiency
SYK leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
SYK delivers a 15.0% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $8 for PHG. SYK carries lower financial leverage with a 0.66x debt-to-equity ratio, signaling a more conservative balance sheet compared to PHG's 0.74x. On the Piotroski fundamental quality scale (0–9), PHG scores 7/9 vs SYK's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +8.2% | +15.0% |
| ROA (TTM)Return on assets | +3.4% | +6.9% |
| ROICReturn on invested capital | +6.4% | +11.4% |
| ROCEReturn on capital employed | +7.1% | +13.0% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.74x | 0.66x |
| Net DebtTotal debt minus cash | $5.3B | $10.8B |
| Cash & Equiv.Liquid assets | $2.8B | $4.0B |
| Total DebtShort + long-term debt | $8.1B | $14.9B |
| Interest CoverageEBIT ÷ Interest expense | 4.34x | 6.72x |
Total Returns (Dividends Reinvested)
PHG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SYK five years ago would be worth $12,108 today (with dividends reinvested), compared to $5,814 for PHG. Over the past 12 months, PHG leads with a +17.0% total return vs SYK's -21.7%. The 3-year compound annual growth rate (CAGR) favors PHG at 11.6% vs SYK's 1.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +0.6% | -15.8% |
| 1-Year ReturnPast 12 months | +17.0% | -21.7% |
| 3-Year ReturnCumulative with dividends | +39.2% | +4.8% |
| 5-Year ReturnCumulative with dividends | -41.9% | +21.1% |
| 10-Year ReturnCumulative with dividends | +47.9% | +185.6% |
| CAGR (3Y)Annualised 3-year return | +11.6% | +1.6% |
Risk & Volatility
Evenly matched — PHG and SYK each lead in 1 of 2 comparable metrics.
Risk & Volatility
SYK is the less volatile stock with a 0.55 beta — it tends to amplify market swings less than PHG's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PHG currently trades 81.4% from its 52-week high vs SYK's 72.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.12x | 0.55x |
| 52-Week HighHighest price in past year | $33.44 | $404.87 |
| 52-Week LowLowest price in past year | $21.95 | $289.91 |
| % of 52W HighCurrent price vs 52-week peak | +81.4% | +72.2% |
| RSI (14)Momentum oscillator 0–100 | 40.5 | 25.4 |
| Avg Volume (50D)Average daily shares traded | 1.0M | 2.0M |
Analyst Outlook
Evenly matched — PHG and SYK each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates PHG as "Hold" and SYK as "Buy". For income investors, PHG offers the higher dividend yield at 1.47% vs SYK's 1.15%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | — | $403.69 |
| # AnalystsCovering analysts | 22 | 50 |
| Dividend YieldAnnual dividend ÷ price | +1.5% | +1.1% |
| Dividend StreakConsecutive years of raises | 1 | 34 |
| Dividend / ShareAnnual DPS | $0.34 | $3.36 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
SYK leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PHG leads in 2 (Valuation Metrics, Total Returns). 2 tied.
PHG vs SYK: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is PHG or SYK a better buy right now?
For growth investors, Stryker Corporation (SYK) is the stronger pick with 11.
2% revenue growth year-over-year, versus -1. 0% for Koninklijke Philips N. V. (PHG). Koninklijke Philips N. V. (PHG) offers the better valuation at 24. 9x trailing P/E (17. 6x forward), making it the more compelling value choice. Analysts rate Stryker Corporation (SYK) a "Buy" — based on 50 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PHG or SYK?
On trailing P/E, Koninklijke Philips N.
V. (PHG) is the cheapest at 24. 9x versus Stryker Corporation at 34. 8x. On forward P/E, Koninklijke Philips N. V. is actually cheaper at 17. 6x.
03Which is the better long-term investment — PHG or SYK?
Over the past 5 years, Stryker Corporation (SYK) delivered a total return of +21.
1%, compared to -41. 9% for Koninklijke Philips N. V. (PHG). Over 10 years, the gap is even starker: SYK returned +185. 6% versus PHG's +47. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PHG or SYK?
By beta (market sensitivity over 5 years), Stryker Corporation (SYK) is the lower-risk stock at 0.
55β versus Koninklijke Philips N. V. 's 1. 12β — meaning PHG is approximately 104% more volatile than SYK relative to the S&P 500. On balance sheet safety, Stryker Corporation (SYK) carries a lower debt/equity ratio of 66% versus 74% for Koninklijke Philips N. V. — giving it more financial flexibility in a downturn.
05Which is growing faster — PHG or SYK?
By revenue growth (latest reported year), Stryker Corporation (SYK) is pulling ahead at 11.
2% versus -1. 0% for Koninklijke Philips N. V. (PHG). On earnings-per-share growth, the picture is similar: Koninklijke Philips N. V. grew EPS 224. 0% year-over-year, compared to 8. 2% for Stryker Corporation. Over a 3-year CAGR, SYK leads at 10. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PHG or SYK?
Stryker Corporation (SYK) is the more profitable company, earning 12.
9% net margin versus 5. 0% for Koninklijke Philips N. V. — meaning it keeps 12. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SYK leads at 19. 5% versus 8. 0% for PHG. At the gross margin level — before operating expenses — SYK leads at 64. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PHG or SYK more undervalued right now?
On forward earnings alone, Koninklijke Philips N.
V. (PHG) trades at 17. 6x forward P/E versus 19. 5x for Stryker Corporation — 1. 9x cheaper on a one-year earnings basis.
08Which pays a better dividend — PHG or SYK?
All stocks in this comparison pay dividends.
Koninklijke Philips N. V. (PHG) offers the highest yield at 1. 5%, versus 1. 1% for Stryker Corporation (SYK).
09Is PHG or SYK better for a retirement portfolio?
For long-horizon retirement investors, Stryker Corporation (SYK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
55), 1. 1% yield, +185. 6% 10Y return). Both have compounded well over 10 years (SYK: +185. 6%, PHG: +47. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PHG and SYK?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.